The Charlson Comorbidity Index: Predicting Severity in Emergency Departments (Charlson)

Objective: The Charlson Comorbidity Index (CCI) is a comorbidity scale used widely throughout the world. It uses patients' preoperative and intraoperative morbidity factors to evaluate morbidity and mortality risk. Though the CCI has widespread use, it has not been evaluated in patients attending at ES, and its relationship with patient readmission has not been shown previously. In this study, we aimed to show whether there is a correlation between the CCI value and the number of repeated admissions to emergency services and that the CCI value can be used as a predicted factor for the serious patients.

Matherials and Methods: This was a prospective observational cross-sectional study. Age, gender, vital signs of the patients who agreed to participate in the study was recorded. Numbers of emergency service applications in the last 6 months and CCI score have been recorded.

Study Overview

• Status: Completed
• Conditions: Emergency Medicine
• Intervention / Treatment: Other: observation

Detailed Description

This study showed that CCI score can be used for identify serious patient in emergency service.

• Study Type: Observational
• Enrollment (Actual): 1

Contacts and Locations

Study Locations

• Turkey
  • Erzurum, Turkey, 25100
    • Abdullah Osman Kocak

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

all patients admitted to the emergency room

Description

Inclusion Criteria:

• Admitted patients were told about the study, and those who agreed to participate were included

Exclusion Criteria:

• Patients who did not wish to participate in the study
• Patients who were unable to work or who had problems with consciousness
• Patients with non-hospital cardiopulmonary arrest
• Patients who had previously participated in the study (readmitted patients)
• Patients who had accessed ES for the same or a similar complaint within the last seven days
• < 18 years' old

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
patient(hospitalized); patients who are admitted to the emergency department and hospitalized.	Other: observation; observation
control(not hospitalized); patients who are admitted to the emergency department and not hospitalized.	Other: observation; observation

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
determine the severity of patients. to identify patients who need hospitalization. determine the severity of patients.	to identify patients who need hospitalization.	2018

Collaborators and Investigators

• Sponsor: Ataturk University

Study record dates

Study Major Dates

• Study Start (ACTUAL): October 1, 2018
• Primary Completion (ACTUAL): October 7, 2018
• Study Completion (ACTUAL): January 1, 2019

Study Registration Dates

• First Submitted: March 26, 2020
• First Submitted That Met QC Criteria: March 30, 2020
• First Posted (ACTUAL): March 31, 2020

Study Record Updates

• Last Update Posted (ACTUAL): March 31, 2020
• Last Update Submitted That Met QC Criteria: March 30, 2020
• Last Verified: March 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Disease Attributes; Emergencies
• Other Study ID Numbers: Ataturkuniversity

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No